A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies

Name: A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
License: Public Domain

Second Affiliated Hospital of Guangzhou Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

acute lymphocytic leukemia, chronic lymphocytic leukemia, lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 311121
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.